Results 161 to 170 of about 20,910 (238)

6-Month Postoperative Magnetic Resonance Imaging Appearance of Osteochondral Allografts With Bone Marrow Aspirate Augmentation From Either the Proximal Tibia or Iliac Crest. [PDF]

Orthop J Sports Med
Retzky JS, Palhares GM, Khilnani TK, Davie R, Xu A, Neijna AG, Rizy ME, Gracitelli GC, Terry HL, Strickland SM, Gomoll AH.   +10 more
europepmc   +1 more source

Psychedelic‐assisted treatment for substance use disorder: A narrative systematic review

Addiction, EarlyView.
Abstract Background and aims This is the first systematic review of the extant literature on all major psychedelic‐assisted treatment for alcohol use disorder (AUD), tobacco use disorder (TUD) and other substance use disorders (SUD). We aimed to summarise the evidence for efficacy of psychedelic‐assisted treatment for AUD, TUD, and SUD; to evaluate its
Theodore Piper, Francesca Small, Sam Brown, Michael Kelleher, Luke Mitcheson, James Rucker, Allan H. Young, John Marsden   +7 more
wiley   +1 more source

Outpatient Total Joint Arthroplasty in an Academic University: Advanced Review of Concepts. [PDF]

Orthop Rev (Pavia)
Constantinescu DS, Lobaton GO, Eskenazi J, Samineni AV, Hernandez V.   +4 more
europepmc   +1 more source

Brief report: Ketamine‐assisted “bridge therapy” for opioid tapering in complex cases

The American Journal on Addictions, EarlyView.
Abstract Background Opioid use disorder (OUD) presents major challenges, especially when combined with chronic pain and psychiatric comorbidities. A 25‐year‐old woman with OUD, chronic pain, and major depressive disorder underwent an 8‐week protocol of intravenous ketamine infusions (0.5 mg/kg weekly) as an adjunct to opioid tapering. Results Methadone
Mariana C. de Oliveira, Cláudia C. de Araujo Palmeira, André B. Negrão, Ziyad A. Hadi, Julia R. Arana, Rita de Cássia Ferreira Duarte, Joice L. P. da Silva, Gustavo K. Matsui, João F. D. Rapozero, Douglas H. Crispim, André Malbergier, João M. Castaldelli‐Maia   +11 more
wiley   +1 more source

Clinical presentation and management of snakebite envenoming in northern Ghana. [PDF]

PLoS Negl Trop Dis
Aglanu LM, Amuasi JH, Duah IK, Agbogbatey MK, Steinhorst J, Adobasom-Anane AG, Bukari Z, Azabu TJ, Kreuels B, Lalloo DG, Stienstra Y.   +10 more
europepmc   +1 more source

Understanding and Addressing Clinical Variation in Rectal Cancer Care: Application of an Analytic Framework

Asia-Pacific Journal of Clinical Oncology, EarlyView.
There is substantial clinical variation in the use of neoadjuvant radiotherapy for high‐risk rectal cancer, ranging from 25% to 59% in New South Wales, Australia. Assessed against an empirically based analytic framework, the reasons for this clinical variation were largely unwarranted and related to MDT processes, imaging quality, workforce/practice ...
Bernadette (Bea) Brown, Daniel Steffens, Michael Solomon, Cherry Koh, Jane Young   +4 more
wiley   +1 more source

Primary Solitary Intra-thyroid Myofibroma in a Pediatric Patient. [PDF]

Cureus
Jensen L, Silva G, Westmoreland T, Miles L.   +3 more
europepmc   +1 more source

The Current Status of Circulating Tumor DNA Utilization in Australasia: A Survey of Thoracic Oncology Group Australasia Members

Asia-Pacific Journal of Clinical Oncology, EarlyView.
This study explores the current status, utilization, and barriers to circulating tumour DNA (ctDNA) testing in thoracic oncology across Australia and New Zealand. While clinicians recognize the potential of ctDNA for guiding targeted therapy and monitoring disease, real‐world access remains inconsistent due to funding, availability, and infrastructure ...
Yifei Zhu, Danyon Lo, Deme Karikos, Malinda Itchins, Annie Wong   +4 more
wiley   +1 more source

Iridocorneal endothelial syndrome. [PDF]

Front Ophthalmol (Lausanne)
Ma H, Xia M, Gu Q, Zheng L, Ha S.
europepmc   +1 more source

Advances and Future Perspectives for the Management of Non‐Small Cell Lung Cancer in Australia: A Narrative Review

Asia-Pacific Journal of Clinical Oncology, EarlyView.
Lung cancer remains Australia's leading cause of cancer death. With new screening and evolving therapies, equitable access and workforce readiness are essential. This review discusses current and emerging treatments for NSCLC in Australia, clinical trials underway, and future directions in delivering optimal, accessible care nationwide.
Lauren Julia Brown, Graham Meredith, Bo Gao, Pei Ding, Harriet Gee, Inês Pires da Silva, Adnan Nagrial, Eric Hau   +7 more
wiley   +1 more source